HIGHLIGHTS
- who: Laurent Chaloin and collaborators from the Centre du00d5etudes du00d5agents Pathogeu2113nes Biotechnologies pour la Sante (CPBS), Institut Biologie, CNRS, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel have published the research work: Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif, in the Journal: (JOURNAL) of 13/Nov/2006
- what: The authors focused the attention to the Rev target. The authors focused on the functional characterization of the Rev-BCPs series bearing the ARM of HIV-1 Rev and the evaluation of their antiviral . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.